THERAPEUTIC HORIZONS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE( MASLD) & METABOLIC DYSFUNCTION ASSOCIATED STEATOHEPATITIS( MASH): A SYSTEMATIC REVIEW OF CURRENT TREATMENT OPTION

被引：0
|
作者：
Moliya, Pratiksha [1 ]
Al-Obaidi, Hasan [1 ]
Patel, Pranav [2 ]
Patel, Raj
Parikh, Charmy [3 ]
Joy, Melvin [4 ]
机构：
[1] Jama Hosp Med Ctr, Jamaica, NY USA
[2] Geisinger Med Ctr, Danville, PA USA
[3] Mercy Catholic Med Ctr, Darby, PA USA
[4] Nassau Univ Med Ctr, East Meadow, NY USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1614
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options
    Portincasa, Piero
    Khalil, Mohamad
    Mahdi, Laura
    Perniola, Valeria
    Idone, Valeria
    Graziani, Annarita
    Baffy, Gyorgy
    Di Ciaula, Agostino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
  • [32] Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis
    Devasia, Arun George
    Ramasamy, Adaikalavan
    Leo, Chen Huei
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [33] Nutrients associated with metabolic dysfunction-associated steatotic liver disease
    Jeong, Seogsong
    JOURNAL OF HEPATOLOGY, 2024, 80 (02) : e81 - e82
  • [34] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
  • [35] IMPROVED DIAGNOSTIC ACCURACY OF VIBRATION-CONTROLLED TRANSIENT ELASTOGRAPHY BASED TESTS IN IDENTIFYING METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND AT-RISK MASH IN OBESE AND LEAN INDIVIDUALS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Quek, Joo Wei Ethan
    Tan, En Ying
    Lee, Shi Yan
    Huang, Daniel
    Lee, Jonathan
    Teng, Margaret
    Ng, Cheng Han
    Syn, Nicholas
    Wee, Aileen
    Soon, Shook Ting Gwyneth
    Jumat, Nur Halisah
    Dan, Yock Young
    Muthiah, Mark
    HEPATOLOGY, 2024, 80 : S620 - S621
  • [36] Quercetin: A Promising Candidate for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
    Markowska, Julia
    Kasprzak-Drozd, Kamila
    Nizinski, Przemyslaw
    Dragan, Magdalena
    Kondracka, Adrianna
    Gondek, Ewa
    Oniszczuk, Tomasz
    Oniszczuk, Anna
    MOLECULES, 2024, 29 (22):
  • [37] Metabolic dysfunction-associated steatotic liver disease and the heart
    Driessen, Stan
    Francque, Sven M.
    Anker, Stefan D.
    Cabezas, Manuel Castro
    Grobbee, Diederick E.
    Tushuizen, Maarten E.
    Holleboom, Adriaan G.
    HEPATOLOGY, 2023,
  • [38] Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
    Stefan, Norbert
    Roden, Michael
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 : S290 - S296
  • [39] EATING DISORDERS IN MEXICAN POPULATION WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD)
    Contreras, Ana D. Cano
    Alvarez, Hector Ricardo Ordaz
    Priego-Parra, Bryan Adrian
    Martinez-Perez, Genesis Patricia
    Reyes-Diaz, Sara A.
    Azamar, Pamela Duran
    Garcia-Carvajal, Mario J.
    Diaz-Crespo, Angel H.
    Vazquez-Cruz, Anette P.
    Hernandez, Tonatiu Castellanos
    Basurto, Jose Luis Vargas
    Dietlen, Federico B. Roesch
    Francisco, Maria D.
    Amieva-Balmori, Mercedes
    Remes-Troche, Jose Maria
    GASTROENTEROLOGY, 2024, 166 (05) : S1649 - S1650
  • [40] Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Orfanidou, Myrsini
    Polyzos, Stergios A.
    MEDICINA-LITHUANIA, 2025, 61 (01):
12345